Jaguar Health, Inc. / Fundamentals
Income statement
- Net revenue
€10.10M - Cost of goods sold
€1.84M - Gross profit
€8.26M - SG&A expenses
€23.12M - R&D expenses
€13.36M - EBITDA
-€33.71M - D&A
€1.50M - EBIT
-€28.18M - Interest expenses
€48.05K - EBT
-€35.53M - Tax expenses
-€113.26K - Net income
-€34.87M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€6.23M - Changes in working capital
€495.07K - Operating cash flow
-€23.75M - Capex
€170.74K - Other investing cash flow
€0.00 - Net investing cash flow
-€184.47K - Total cash dividends paid
€0.00 - Issuance of common stock
€7.08M - Debt repayment
€63.49K - Other financing cash flow
€4.86M - Net financing cash flow
€12.00M - Foreign exchange effects
€27.46K - Net change in cash
-€11.88M - Cash at end of period
€1.89M - Free cash flow
-€23.58M
Balance sheet
- Cash and cash equivalents
€1.89M - Cash and short-term investments
€1.89M - Total receivables
€1.13M - Inventory
€9.20M - Other current assets
€11.72M - Total current assets
€23.94M - Property, plant & equipment
€1.35M - Goodwill
€0.00 - Intangible assets
€15.05M - Long-term investments
€0.00 - Other non-current assets
€1.06M - Total non-current assets
€17.47M - Total assets
€41.41M - Accounts payable
€5.68M - Short-term debt
€16.15M - Other current liabilities
€3.09M - Total current liabilities
€25.07M - Long-term debt
€10.04M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€10.44M - Total liabilities
€35.51M - Common stock
€0.00 - Retained earnings
-€315.19M - Other equity
-€616.90K - Total equity
€5.90M - Total liabilities and shareholders' equity
€41.41M
Company information
- Market capitalization
€2.82M - Employees
49 - Enterprise Value
€37.46M
Company ratios
- Gross margin
-
81.8% Much worse than peer group: 543,852,529,135,152,600.0% - EBITDA margin
-
-333.9% Much worse than peer group: 3,842,868,617,809,890,400.0% - EBIT margin
-
-279.1% Much worse than peer group: 3,273,130,064,324,423,000.0% - EBT margin
-
-351.9% Much worse than peer group: 1,024,424,665,411,268,000,000.0% - Net margin
-
-345.4% Much better than peer group: -867,740,817,354,384,600.0% - ROE
-
-590.8% Much worse than peer group: -453.5% - ROA
-
-84.2% Much better than peer group: -387.1% - Asset turnover
-
24.4% Much worse than peer group: 45.7% - FCF margin
-
-236.9% Much worse than peer group: 2,511,596,989,999,028,000.0% - FCF yield
-846.8% - Efficiency ratio
433.9% - Net sales per employee
-
€206.04K - Net income per employee
-
-€711.70K